ANRIL, MALAT1, and PICART1 had the diagnostic power of 0.96, 0.94, and 0.92 in distinguishing between cases with CIDP and controls, respectively. Here, CDKN2B-AS1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.